elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34057466-4F29225D-3D02-46D2-9E4E-6AECABED0994
Q34057466-4F29225D-3D02-46D2-9E4E-6AECABED0994
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34057466-4F29225D-3D02-46D2-9E4E-6AECABED0994
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.
P2860
Q34057466-4F29225D-3D02-46D2-9E4E-6AECABED0994
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34057466-4F29225D-3D02-46D2-9E4E-6AECABED0994
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b5c65529d26067bc0a0949b045c67c990aa06efb
P2860
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.